Back to Search Start Over

Teclistamab in Relapsed or Refractory Multiple Myeloma.

Authors :
Cliff ERS
Mian H
Mohyuddin GR
Source :
The New England journal of medicine [N Engl J Med] 2022 Nov 03; Vol. 387 (18), pp. 1721-1722.
Publication Year :
2022

Subjects

Subjects :
Humans
Neoplasm Recurrence, Local drug therapy
Antineoplastic Combined Chemotherapy Protocols
Multiple Myeloma drug therapy
Antineoplastic Agents therapeutic use
Antibodies, Bispecific therapeutic use

Details

Language :
English
ISSN :
1533-4406
Volume :
387
Issue :
18
Database :
MEDLINE
Journal :
The New England journal of medicine
Publication Type :
Editorial & Opinion
Accession number :
36322860
Full Text :
https://doi.org/10.1056/NEJMc2211969
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details